Zobrazeno 1 - 10
of 1 233
pro vyhledávání: '"Monoclonal immunoglobulin"'
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-8 (2024)
Abstract Background Monoclonal immunoglobulin deposition disease (MIDD) is characterized by the deposition of nonamyloid monoclonal immunoglobulin and its free fragment light chain and/or heavy chain in systemic tissues and organs, and the kidney is
Externí odkaz:
https://doaj.org/article/3456d819812c445a8d025e481b948772
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundWe found that a subset of patients with monoclonal gammopathy exhibited hypercalcemia without apparent causes or clinical manifestations In a cohort of 289 monoclonal gammopathy patients, 2.4% presented with such atypical hypercalcemia, wit
Externí odkaz:
https://doaj.org/article/bf43dafa7e834f2fb2c19df8cd8d0b96
Publikováno v:
Journal of Mass Spectrometry and Advances in the Clinical Lab, Vol 32, Iss , Pp 31-40 (2024)
Introduction: The EXENT® Solution, a fully automated system, is a recent advancement for identifying and quantifying monoclonal immunoglobulins in serum. It combines immunoprecipitation with MALDI-TOF mass spectrometry. Compared to gel-based methods
Externí odkaz:
https://doaj.org/article/705dc139046a400490d09a49a9826386
Autor:
FAN Hongming, GUO Dan, HONG Lemin, HUANG Chunqun, LU Jinfeng, XU Honghui, CHEN Jie, HUANG Hongming, YANG Xi
Publikováno v:
Zhongguo linchuang yanjiu, Vol 37, Iss 6, Pp 925-928,954 (2024)
Objective To investigate the clinical characteristics of indolent B-cell non-Hodgkin lymphoma (iB-NHL) with monoclonal immunoglobulin (McIg). Methods The clinical and pathological data of 82 newly diagnosed iB-NHL patients in the Affiliated Hospital
Externí odkaz:
https://doaj.org/article/884cd156981e4167b045cfe0ffb938db
Autor:
Maho Terashita, Umut Selamet, Shonali Midha, Omar Nadeem, Jacob Laubach, Helmut G. Rennke, Naoka Murakami
Publikováno v:
Kidney International Reports, Vol 8, Iss 12, Pp 2765-2777 (2023)
Introduction: Monoclonal gammopathy of renal significance (MGRS) is characterized by monoclonal immunoglobulin deposition in kidneys. However, monoclonal immunoglobulin and responsible clone(s) are not always detectable. Treatment response and kidney
Externí odkaz:
https://doaj.org/article/0cd6ba13dbd94655b120bb5a4b389679
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
RationaleMonoclonal gammopathy of renal significance (MGRS) represents a group of disorders caused by monoclonal immunoglobulin (M protein) secreted by B cells or plasma cells. Proliferative glomerulonephritis with monoclonal immunoglobulin depositio
Externí odkaz:
https://doaj.org/article/8427fc317b6a4cf080426c458828ec80
Autor:
Li Zhu, Lei Wang, Hongxia Shi, Lei Jiang, Xin Li, Chunying Shao, Yu Yan, Bao Dong, Wanzhong Zou, Li Zuo
Publikováno v:
Renal Failure, Vol 45, Iss 1 (2023)
AbstractBackground Crystal-storing histiocytosis (CSH), light chain proximal tubulopathy (LCPT), and light chain crystalline podocytopathy (LCCP) are rare complications of multiple myeloma (MM) or monoclonal gammopathy of renal significance, and thei
Externí odkaz:
https://doaj.org/article/ca463e81fa2a4cbeb836507ee6b73c12
Publikováno v:
Clinical, Cosmetic and Investigational Dermatology, Vol Volume 16, Pp 987-993 (2023)
Shunyu Yao,1,2 Suxia Wang,3,* Runxi Yi,1,4,* Liwei Ran,5 Cang Zhang2 1Chinese Traditional Medicine, Beijing University of Chinese Medicine, Beijing, People’s Republic of China; 2Department of Dermatology, Beijing Hospital of Traditional Chi
Externí odkaz:
https://doaj.org/article/bdb785f0b84644388972de14275acf4b
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Subsets of patients diagnosed with a monoclonal gammopathy of undetermined significance (MGUS), smoldering multiple myeloma (SMM) or multiple myeloma (MM), present with a monoclonal immunoglobulin (Ig) specific for an infectious pathogen, including h
Externí odkaz:
https://doaj.org/article/df248dacaf5e4caebd391bab8cab15de
Autor:
Ivan Krečak, Velka Gverić-Krečak
Publikováno v:
Acta Clinica Croatica, Vol 62., Iss 2, Pp 382-385 (2023)
Despite being extremely rare, Guillain-Barré syndrome (GBS) has been recognized as a neurological complication of multiple myeloma, with variable responses to plasmapheresis (PEX), intravenous immunoglobulins (IVIG), and anti-myeloma therapies. In
Externí odkaz:
https://doaj.org/article/3456817303c44e5d9af0a7e9fb5d6035